BIOMAT Database Logo BIOMAT Database Logo

[Mycobacterium tuberculosis lipases, new targets in the fight against tuberculosis]. 2022

Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
Master 2 Microbiologie intégrative et fondamentale, Aix Marseille Université, Marseille, France.

UI MeSH Term Description Entries
D008049 Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3. Triacylglycerol Lipase,Tributyrinase,Triglyceride Lipase,Acid Lipase,Acid Lipase A,Acid Lipase B,Acid Lipase I,Acid Lipase II,Exolipase,Monoester Lipase,Triacylglycerol Hydrolase,Triglyceridase,Triolean Hydrolase,Hydrolase, Triacylglycerol,Hydrolase, Triolean,Lipase A, Acid,Lipase B, Acid,Lipase I, Acid,Lipase II, Acid,Lipase, Acid,Lipase, Monoester,Lipase, Triglyceride
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
Setting new targets in the fight against tuberculosis.
March 2013, Nature medicine,
Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
Artificial intelligence in drug discovery: A new frontier in the fight against Mycobacterium tuberculosis.
February 2024, Drug discovery today,
Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
Rifampin, new hope in the fight against tuberculosis.
September 1970, The New England journal of medicine,
Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
Spirocyclic compounds: potential drug leads in the fight against Mycobacterium tuberculosis.
April 2025, Future medicinal chemistry,
Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
New drug targets for Mycobacterium tuberculosis.
January 2003, The Indian journal of medical research,
Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
The Methylerythritol Phosphate Pathway: Promising Drug Targets in the Fight against Tuberculosis.
March 2018, ACS infectious diseases,
Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
New vaccines enter fray in fight against tuberculosis.
January 2004, Nature medicine,
Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
The fight against tuberculosis.
June 2006, Molecular interventions,
Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
[The fight against tuberculosis].
March 1965, El Torax,
Gwendoline Degré, and Jonas Desjardins, and Julien Garcia, and Clément Vanderstraeten, and Jérémy Wozniak, and Amel Latifi
The fight against tuberculosis.
January 1946, Revue de dietetique,
Copied contents to your clipboard!